Cardinal Health is trading 5.7% up at $254.15 in pre-market, with no clear company-specific announcement identified for September 9, 2026.

  • Recent bullish commentary from Jim Cramer and strong fiscal 2027 guidance are older catalysts, not new overnight developments.
  • An available article reports no September 8–9 press releases, filings, acquisitions, or analyst actions.
  • Healthcare is down 2.52% pre-market, so sector weakness does not explain the gain.